Home » Newsletters » BioWorld Science

BioWorld Science

July 1, 2016

View Archived Issues

GeoVax Labs receives award from NIH for HIV vaccine program for Africa

Takeda initiates first-in-human study of TAK-041

Cancer Genetics offers Ventana PD-L1 assay as complementary diagnostic for Tecentriq

HXP-124 as a novel antifungal agent for the treatment for onychomycosis

Novel ARF6 inhibitors with robust in vivo efficacy

Ampio announces results from phase III PIVOT clinical trial

Galderma Research & Development patents retinoid RORgammaT inverse agonists

Laboratorios del Dr. Esteve discloses dual sigma1 and mu-opioid receptor ligands

PharmNovo describes delta-opioid agonists

Morphic Therapeutic completes series A financing to develop next-generation integrin therapies

Janssen Pharmaceutica develops BACE1 and/or BACE2 inhibitors

Gilead Sciences presents FXR agonists

Regen Biopharma enters deal with Eli lilly

New class of small molecules enhances oncolytic virus replication

Eli Lilly initiates phase I trial of LY-3300054 in advanced refractory solid tumors

PsiOxus, BMS to evaluate enadenotucirev plus nivolumab

Array BioPharma submits NDA for binimetinib for advanced NRAS-mutant melanoma

AstraZeneca and Leo Pharma announce licensing agreements for tralokinumab and brodalumab

Sprint Bioscience partners with Karolinska research team in AML

Takeda Pharmaceuticals begins collaboration with Exosome Diagnostics

Targovax initiates phase Ib/II trial of ONCOS-102 in malignant pleural mesothelioma

GS-9883 found to reduce HIV-1 RNA in clinical trial

Gedeon Richter announces acquisition of Finox

Akers Biosciences completes trial of PIFA/Chlamydia Rapid Assay

Phase II study of Shire's SHP-607 misses primary endpoint

Galmed Pharmaceuticals enters collaboration with Yeda Research and Development

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 12, 2025
At CROI, HIV cure trials raise hopes for broader applicability
BioWorld
At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...
Hummingbird migrates ADCs, tech to newco Callio’s $187M debut
BioWorld
Antibody-drug conjugate (ADC)-focused Callio Therapeutics debuted on March 3 with the closing of a $187 million series A financing round based on cancer drug...